Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free mediumAtkins, G.; Kostakis, P.; Welldon, K.; Vincent, C.; Findlay, D.; Zannettino, A.
2005Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kBMorgan, T.; Atkins, G.; Trivett, M.; Johnson, S.; Kansara, M.; Schlicht, S.; Slavin, J.; Simmons, P.; Dickinson, I.; Powell, G.; Choong, P.; Holloway, A.; Thomas, D.
2005An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factorsZannettino, A.; Farrugia, A.; To, L.; Atkins, G.; Brown, R.; Joy Ho, P.
2009Biomimetic hydroxyapatite coating on glass coverslips for the assay of osteoclast activity in vitroWijenayaka, A.; Colby, C.; Atkins, G.; Majewski, P.
2010Osteoclastic metabolism of 25(OH)-vitamin D-3: A potential mechanism for optimization of bone resorptionKogawa, M.; Findlay, D.; Anderson, P.; Ormsby, R.; Vincent, C.; Morris, H.; Atkins, G.
2008Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2009Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaLabrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2011Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathwayWijenayaka, A.; Kogawa, M.; Lim, H.; Bonewald, L.; Findlay, D.; Atkins, G.; Carvalho, D.P.D.